Synthetic human parathyroid hormone 1-34 replacement therapy: a randomized crossover trial comparing pump versus injections in the treatment of chronic hypoparathyroidism.

Abstract

Pump delivery of PTH 1-34 provides the closest approach to date to physiological replacement therapy for hypoparathyroidism.

Full Text

DOI - (DOI)
Ovid Technologies, Inc. - full-text online
HighWire Press - full-text online
EBSCO - full-text online

Subjects

Similar articles

Effects of once versus twice-daily parathyroid hormone 1-34 therapy in children with hypoparathyroidism. (2008-09-05)
Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1-34 versus calcitriol and calcium. (2010-06-07)
Therapy of hypoparathyroidism with intact parathyroid hormone. (2010-09-29)
Daily parathyroid hormone 1-34 replacement therapy for hypoparathyroidism induces marked changes in bone turnover and structure. (2012-07-18)
PTH 1-34 Replacement Therapy in a Child With Hypoparathyroidism Due to a Sporadic Calcium Receptor Mutation. (2008-12-09)
Recombinant Human Parathyroid Hormone Therapy (1-34) in an Adult Patient with a Gain-of-Function Mutation in the Calcium-Sensing Receptor-A Case Report. (2012-11-29)
[Rhabdomyolysis in a patient with postoperative hypothyroidism and hypoparathyroidism] (2008-03-05)
Long-term results of continuous subcutaneous recombinant PTH (1-34) infusion in children with refractory hypoparathyroidism. (2011-11-07)
PTH replacement therapy of hypoparathyroidism. (2012-11-27)

Authors

Publication date

2012-02-07

Journal

The Journal of clinical endocrinology and metabolism
J Clin Endocrinol Metab (1945-7197)

Journal topics

Language

Eng.

Copyright

The Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland 20892-7510, USA. winerk [at] mail.nih.gov

Release reference

J Clin Endocrinol Metab. 2012 Feb;97(2):391-9

Related books

Español | English

© Galenicom 1999-2013